SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is seeing a surge in investor interest driven by strong technical momentum and persistent talk of a potential short squeeze, as shares approach a key resistance level near $30. The community is actively discussing the stock's growth potential fueled by upcoming peptide announcements and the recent expansion of GLP-1 weight-loss offerings.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing intense community debate as investors weigh the stock's recent volatility against its potential as an AI infrastructure play, with many bullish participants pointing to recent hiring activity and capacity expansion as indicators of underlying demand. While short-term traders track technical support levels and broader market macro pressures, long-term holders remain focused on upcoming catalyst events and potential institutional re-positioning.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending following the abrupt departure of CEO Mike Lyons and the immediate appointment of Takis Georgakopoulos, a transition that has triggered significant volatility and investor concern over the company's growth outlook. While some market participants view the leadership change as a necessary reset and a potential long-term value play, the community remains divided, with active discussions focused on the companys recent earnings performance, industry-wide fintech valuation pressures, and the potential for activist intervention.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku shares are surging following a strong quarterly earnings report that featured a significant beat on revenue and a subscriber milestone of over 100 million households. The community is actively discussing the wave of positive analyst price target hikes and questioning whether the stock can maintain this momentum toward higher levels.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as investors grapple with conflicting sentiment, ranging from long-term value-based optimism regarding its AI and cloud infrastructure to intense frustration over persistent price stagnation and geopolitical regulatory pressures. The community remains deeply polarized, with many retail traders debating whether the stock serves as a prime opportunity for accumulation at historical discounts or remains a structurally compromised value trap.

BTQ Technologies Corp. engages in the business of post-quantum encryption. Its products include: QCIM, QSSN, OSS, QPoW, QRiNG. The company was founded by Nicolas Roussy Newton on Novemeber 23, 1983 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is drawing significant community attention as investors debate its role in the quantum-secure infrastructure sector, with discussion centered on technical support levels and speculation regarding potential commercial contracts or acquisition activity. While some traders are focused on technical chart patterns and potential bottoming, others remain cautious due to limited commercial revenue and ongoing public disputes within the company's leadership.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is experiencing significant institutional momentum, highlighted by a sharp increase in price targets from analysts at firms like Morgan Stanley and Bernstein, who cite the company's successful pivot from Bitcoin mining to high-performance AI infrastructure as a major catalyst. The community is actively discussing the stock's potential for further upside as they monitor progress on the company's multi-gigawatt development pipeline and the highly anticipated announcement of a new customer for its Kentucky site.

Fox Corp. engages in providing television production and broadcasting services. It also provides news under the brands FOX News Media, FOX Sports, FOX Entertainment and FOX Television Stations, and Tubi Media Group. It operates through the following segments: Cable Network Programming, Television, and Other and Corporate. The Cable Network Programming segment refers to the production and licensing of news and sports content distributed primarily through traditional cable television systems, direct broadcast satellite operators, and telecommunication companies and online multi-channel video programming distributors. The Television segment focuses on the acquisition, marketing, and distribution of broadcast network programming. The Other and Corporate segment relates to the FOX Studio Lot, Credible Labs Inc, corporate overhead costs, and intracompany eliminations. The company was founded by Keith Rupert Murdoch on May 3, 2018, and is headquartered in New York, NY.

Fox Corporation - Ordinary Shares - Class A

Fox Corporation

Fox is seeing significant market activity as investors weigh the strategic implications of its major $22 billion acquisition of Roku, with debate centering on the company's aggressive push into streaming and the potential impact on shareholder dilution and leverage. Community members are actively discussing the high valuation and long-term consolidation logic of the deal, while simultaneously tracking stock price volatility in response to the announcement.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point for investors due to positive Phase 3 data for its gene-editing therapy, with the community closely tracking the stock's potential for a short squeeze alongside institutional accumulation and upcoming regulatory milestones. Traders are actively debating the impact of a recent share offering and the company's long-term commercialization prospects, viewing the current price as an inflection point for the stock's valuation.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzle is trending as investors weigh a strong Q1 earnings beat and raised guidance against a high short interest, fueling intense community debate regarding a potential short squeeze. While the company's expansion into an all-in-one financial app and institutional accumulation drive bullish sentiment, some investors remain cautious due to recent corporate governance concerns and broader market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IBRX $IOVA The complex scalability, cost and nominal efficacy make IOVA a pale choice against IBRX

cyberInvest

Lindzcav

Justlosing

Charles ford

FL Man

StockTwits for iOS

Iovance Biotherapeutics Inc

ImmunityBio Inc

$IOVA $IBRX the not dying of cancer makes IBRX a pale choice against IOVA.

barbaresqo

$IBRX $IOVA here is one with bait and switch

 The complex scalability, cost and nominal efficacy make IOVA a pale choice against IBRX

Pork fried rice

@Adi121 they’re desperate. I don’t believe anyone posts there from here.

Chad Schott

 they’re desperate. I don’t believe anyone posts there from here.

StockTwits Web

Jeff Poburka

@Adi121 IBRX financials are much worse and in biotech, cash runway is king.  Until you have a path to profitability, biotech is only a trade.

Fire_Truck

Kevin Roger

Scooot

Raylin Jones

 IBRX financials are much worse and in biotech, cash runway is king.  Until you have a path to profitability, biotech is only a trade.

George Hansen

@GMH21 research IBRX owner and its rate of revenue growth, you will get some enlightenment! I have no beef against you guys, don’t come on IBRX board to post trash. IBRX is a global play for longevity, cancer and other incurable viral diseases  that makes every human a potential recepient!

 research IBRX owner and its rate of revenue growth, you will get some enlightenment! I have no beef against you guys, don’t come on IBRX board to post trash. IBRX is a global play for longevity, cancer and other incurable viral diseases  that makes every human a potential recepient!

@Adi121 Read the financials... dilution is the death knell of biotech.  Yes, founder owns 80% of the shares... and that is part of the problem.  Low float so the SP gets pumped, but then they need to raise cash and SP gets cut in half.  They have always run on 1-2 quarters of cash.  Operating cashflow consistently negative $70-80M and current cash $90M.  If I were to play IBRX, I would buy the next dilution and flip in &lt;90 days.

Bilar

 Read the financials... dilution is the death knell of biotech.  Yes, founder owns 80% of the shares... and that is part of the problem.  Low float so the SP gets pumped, but then they need to raise cash and SP gets cut in half.  They have always run on 1-2 quarters of cash.  Operating cashflow consistently negative $70-80M and current cash $90M.  If I were to play IBRX, I would buy the next dilution and flip in <90 days.

@GMH21 ok let me tell you one thing ,  IOVA sales peak this year. You can bookmark it and come back next year!

 ok let me tell you one thing ,  IOVA sales peak this year. You can bookmark it and come back next year!

@Adi121 If that is your thesis, then fine. Don&#39;t invest in IOVA.  I do not care, I never asked you too and if you do or do not, it will not make one bit of difference to the share price.

Bi Low Sell Higher

 If that is your thesis, then fine. Don't invest in IOVA.  I do not care, I never asked you too and if you do or do not, it will not make one bit of difference to the share price.

@Adi121 I understand the other guy started it but cross posting is a fool’s errand. Doubly so when it’s done without respect or due diligence.

Real AF biznas

 I understand the other guy started it but cross posting is a fool’s errand. Doubly so when it’s done without respect or due diligence.